Development of contrast agents targeted to macrophage scavenger receptors for MRI of vascular inflammation.
about
In vivo mapping of vascular inflammation using multimodal imagingDetecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI.Bioresponsive, cell-penetrating, and multimeric MR contrast agents.Paramagnetic, silicon quantum dots for magnetic resonance and two-photon imaging of macrophages.Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.Novel method to label solid lipid nanoparticles with 64cu for positron emission tomography imaging.PET Imaging and Biodistribution of Silicon Quantum Dots in Mice.Receptor-targeted iron oxide nanoparticles for molecular MR imaging of inflamed atherosclerotic plaques.Simultaneous in vivo positron emission tomography and magnetic resonance imaging.Strategies for Target-Specific Contrast Agents for Magnetic Resonance ImagingSynthesis of 64Cu-labeled magnetic nanoparticles for multimodal imaging.Multimodality PET/MRI agents targeted to activated macrophages.In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging.Noninvasive cell-tracking methods.Quantitative assessment of binding affinities for nanoparticles targeted to vulnerable plaque.Glycolaldehyde and maleyl conjugated human serum albumin as potential macrophage-targeting carriers for molecular imaging purposes.
P2860
Q27318329-83F0502B-3CC8-415A-A9B7-5DB50D75523AQ33268808-A5520E2F-651C-439B-8368-0BF541ADE9F0Q33470566-DF1108BE-69F8-4149-A547-8EDD437BD594Q33525666-6CF0AD87-1B93-434A-9E35-8BAD402786EAQ33847006-F1323BD9-7367-4AE8-A054-7C0799C4EECAQ34906375-B0DBED38-B1B2-4A2A-AD1F-936559290EFCQ34909815-72A7AFA6-602A-4909-8F64-48016547BE3AQ35141753-7E12A439-E467-4A6C-8235-D5F8117252FAQ36499125-50DAC14A-1CC1-413D-865C-45EEC5835949Q36517070-ACA72B74-7F2C-4B7E-BFDB-32B1BB78BAE8Q36892360-A4703EC6-F142-4243-B032-AABAED71E947Q37625234-2B4F0E04-7871-478F-8338-23E463FA5057Q37668307-0DA7F8E5-A71A-4A93-83EE-5301278FFA78Q37938642-62AC1C5B-36B4-46DD-9B05-0EBD895308D2Q38875454-EB7AAC57-80E6-4958-BF94-CDC8A3BE8248Q42690584-CE04DA50-CB99-412E-BD45-4E74D1DABE4E
P2860
Development of contrast agents targeted to macrophage scavenger receptors for MRI of vascular inflammation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Development of contrast agents ...... MRI of vascular inflammation.
@en
type
label
Development of contrast agents ...... MRI of vascular inflammation.
@en
prefLabel
Development of contrast agents ...... MRI of vascular inflammation.
@en
P2860
P356
P1476
Development of contrast agents ...... r MRI of vascular inflammation
@en
P2093
Angelique Y Louie
Susan Youens
P2860
P304
P356
10.1021/BC060018K
P577
2006-03-01T00:00:00Z